TOFACITINIB CITRATE

TOFACITINIB CITRATE was reported 13404 times

TOFACITINIB CITRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATIC ENZYME 81 0.5436
1 THIOPURINE METHYLTRANSFERASE DECREASED 18 0.5294
2 LUPUS VULGARIS 584 0.4635
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 298 0.4461
4 SYNOVIAL FLUID ANALYSIS 36 0.4138
5 SWOLLEN JOINT COUNT INCREASED 1270 0.3979
6 RHEUMATIC FEVER 1663 0.3727
7 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2580 0.3597
8 RHEUMATOID FACTOR POSITIVE 2072 0.3584
9 SWOLLEN JOINT COUNT 84 0.3360
10 DEEP VEIN THROMBOSIS POSTOPERATIVE 660 0.3295
11 ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA 11 0.3235
12 HYPOCHOLESTEROLAEMIA 111 0.3144
13 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE 7 0.3043
14 DUODENAL ULCER PERFORATION 2095 0.2814
15 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 578 0.2787
16 DISLOCATION OF VERTEBRA 635 0.2781
17 FACET JOINT SYNDROME 857 0.2630
18 X-RAY ABNORMAL 449 0.2508
19 PEMPHIGUS 3014 0.2408
20 HAND DEFORMITY 3049 0.2322
21 RETINITIS 394 0.2279
22 C-REACTIVE PROTEIN 204 0.2201
23 GRIP STRENGTH 50 0.2183
24 SERONEGATIVE ARTHRITIS 248 0.2164
25 HELICOBACTER INFECTION 2125 0.2066
26 SHORT STATURE 52 0.1985
27 PERIPHERAL VENOUS DISEASE 785 0.1920
28 INTESTINAL INTRAEPITHELIAL LYMPHOCYTES INCREASED 12 0.1791
29 SYNOVITIS 3184 0.1764
30 PERICARDITIS 2722 0.1619
31 MUSCLE INJURY 1330 0.1604
32 ERYTHEMA ELEVATUM DIUTINUM 7 0.1522
33 DRUG TOLERANCE DECREASED 425 0.1512
34 MICROVILLOUS INCLUSION DISEASE 11 0.1467
35 FOLLICULITIS 1489 0.1419
36 ACQUIRED PORPHYRIA 10 0.1408
37 C-REACTIVE PROTEIN ABNORMAL 903 0.1406
38 OVERLAP SYNDROME 98 0.1400
39 IMMUNE RECOVERY UVEITIS 8 0.1379
40 GLOSSODYNIA 3044 0.1358
41 BREAST CANCER STAGE III 863 0.1331
42 BONE EROSION 422 0.1192
43 PORPHYRIA ACUTE 171 0.1192
44 TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME 7 0.1167
45 STEROID DEPENDENCE 100 0.1139
46 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 736 0.1132
47 WOUND 2993 0.1070
48 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 60 0.1070
49 BACTERIAL VULVOVAGINITIS 29 0.1003
50 TORUS FRACTURE 7 0.0986
51 SPINAL INSTABILITY 25 0.0984
52 VEXAS SYNDROME 9 0.0938
53 LIP DRY 847 0.0932
54 WOUND INFECTION 1020 0.0930
55 RHEUMATOID FACTOR 10 0.0926
56 CONTRAINDICATED PRODUCT ADMINISTERED 2798 0.0923
57 PROBIOTIC THERAPY 9 0.0909
58 BLEPHAROSPASM 569 0.0903
59 DEATH NEONATAL 125 0.0898
60 HYPERCHOLESTEROLAEMIA 851 0.0880
61 JOINT RANGE OF MOTION DECREASED 1178 0.0877
62 SYSTEMIC LUPUS ERYTHEMATOSUS 3104 0.0874
63 BACTERIAL TRACHEITIS 7 0.0864
64 CRYPTITIS 12 0.0863
65 GRIP STRENGTH DECREASED 729 0.0827
66 LIVE BIRTH 688 0.0822
67 ATLANTOAXIAL INSTABILITY 9 0.0811
68 CATARRH 73 0.0808
69 GRANULOMA SKIN 65 0.0792
70 BURSITIS 941 0.0775
71 MEDICAL DEVICE SITE JOINT INFECTION 12 0.0769
72 HYPERTENSIVE CARDIOMYOPATHY 20 0.0719
73 SPINAL CORD INJURY CERVICAL 18 0.0714
74 IRRITABLE BOWEL SYNDROME 1477 0.0688
75 WRIST DEFORMITY 42 0.0683
76 TENOSYNOVITIS STENOSANS 38 0.0682
77 AUTOIMMUNE DISORDER 644 0.0660
78 ONYCHOMADESIS 276 0.0657
79 FIBROMYALGIA 1596 0.0656
80 PHYSICAL DECONDITIONING 166 0.0644
81 TYPE 2 DIABETES MELLITUS 2004 0.0595
82 LIVER INJURY 1441 0.0586
83 NAIL DISORDER 507 0.0579
84 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 6 0.0571
85 MYELOMALACIA 6 0.0571
86 HERPES ZOSTER INFECTION NEUROLOGICAL 9 0.0566
87 EPIDURAL LIPOMATOSIS 19 0.0552
88 RED BLOOD CELL SEDIMENTATION RATE INCREASED 603 0.0544
89 MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION 17 0.0543
90 ONYCHOMYCOSIS 233 0.0531
91 ARTHROPATHY 2890 0.0519
92 AUTOINFLAMMATORY DISEASE 11 0.0519
93 PRESCRIBED OVERDOSE 992 0.0512
94 EYE INJURY 154 0.0506
95 MYCOBACTERIUM CHELONAE INFECTION 37 0.0501
96 OBESITY 771 0.0483
97 ANTICIPATORY ANXIETY 13 0.0478
98 LUPUS-LIKE SYNDROME 423 0.0466
99 ULTRASOUND DOPPLER ABNORMAL 8 0.0462
100 HIP ARTHROPLASTY 706 0.0461
101 RED BLOOD CELL SEDIMENTATION RATE DECREASED 12 0.0460
102 EXOSTOSIS 414 0.0453
103 STOMA SITE ULCER 8 0.0452
104 IMPAIRED HEALING 1480 0.0450
105 WALKING AID USER 296 0.0448
106 RHEUMATOID NODULE 123 0.0446
107 SCIATICA 710 0.0445
108 THERAPEUTIC PRODUCT EFFECT DECREASED 1991 0.0444
109 INFUSION RELATED REACTION 2937 0.0443
110 BLOOD CHOLESTEROL INCREASED 2057 0.0441
111 BLOOD PARATHYROID HORMONE DECREASED 65 0.0438
112 HERPES ZOSTER MENINGITIS 8 0.0437
113 BURNS SECOND DEGREE 76 0.0433
114 DISCOMFORT 2635 0.0431
115 BACILLUS INFECTION 27 0.0427
116 PROMINENT EPICANTHAL FOLDS 6 0.0426
117 PSORIATIC ARTHROPATHY 1712 0.0421
118 HEPATIC ENZYME INCREASED 2866 0.0420
119 SYNOVIAL DISORDER 19 0.0418
120 MATERNAL EXPOSURE TIMING UNSPECIFIED 157 0.0418
121 PULMONARY FIBROSIS 800 0.0417
122 SALPINGO-OOPHORECTOMY BILATERAL 8 0.0396
123 PRESCRIBED UNDERDOSE 787 0.0394
124 LOWER LIMB FRACTURE 755 0.0393
125 APOPTOSIS 12 0.0388
126 FINGER DEFORMITY 188 0.0388
127 ULCER HAEMORRHAGE 262 0.0387
128 NAIL OPERATION 16 0.0386
129 EXTREMITY CONTRACTURE 24 0.0375
130 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 86 0.0373
131 DRUG INTOLERANCE 3562 0.0368
132 SPONDYLITIS 134 0.0368
133 CUSHINGOID 116 0.0361
134 RHEUMATOID ARTHRITIS 4044 0.0356
135 JOINT DISLOCATION 376 0.0355
136 TREATMENT FAILURE 2932 0.0354
137 CENTRAL OBESITY 26 0.0352
138 PRODUCT LABEL CONFUSION 205 0.0351
139 EAR INJURY 17 0.0343
140 INFUSION SITE REACTION 102 0.0341
141 BLOOD CHOLESTEROL 16 0.0337
142 HERPES OESOPHAGITIS 7 0.0327
143 BLISTER 1823 0.0324
144 ARTHRODESIS 33 0.0324
145 KNEE ARTHROPLASTY 673 0.0319
146 SCLERITIS 51 0.0318
147 JOINT ANKYLOSIS 18 0.0317
148 NECK DEFORMITY 14 0.0315
149 SWELLING 2951 0.0315
150 SEPTIC PULMONARY EMBOLISM 6 0.0308
151 ANTIPHOSPHOLIPID ANTIBODIES 6 0.0308
152 PLASMABLASTIC LYMPHOMA 11 0.0307
153 C-REACTIVE PROTEIN INCREASED 1104 0.0303
154 JOINT DESTRUCTION 46 0.0296
155 BREAST CANCER STAGE II 246 0.0295
156 PERFORATION 23 0.0285
157 PANNICULITIS 68 0.0281
158 LOWER RESPIRATORY TRACT INFECTION 1271 0.0279
159 BONE SWELLING 27 0.0279
160 GAIT INABILITY 927 0.0277
161 BACK INJURY 301 0.0277
162 JOINT SWELLING 3327 0.0275
163 MATERNAL EXPOSURE DURING PREGNANCY 2453 0.0275
164 PUSTULAR PSORIASIS 94 0.0273
165 NIGHT SWEATS 857 0.0266
166 FOOT DEFORMITY 293 0.0264
167 PROCTOCOLECTOMY 8 0.0262
168 CYSTITIS VIRAL 10 0.0261
169 OSTEOARTHRITIS 1091 0.0257
170 TASTE DISORDER 519 0.0256
171 DACTYLITIS 25 0.0255
172 MUSCULOSKELETAL STIFFNESS 2213 0.0252
173 MOBILITY DECREASED 1807 0.0251
174 NODULAR REGENERATIVE HYPERPLASIA 16 0.0249
175 ALCOHOL POISONING 65 0.0242
176 RESPIRATORY TRACT INFECTION BACTERIAL 12 0.0241
177 MAJOR DEPRESSION 176 0.0241
178 COELIAC DISEASE 236 0.0240
179 LARGE GRANULAR LYMPHOCYTOSIS 8 0.0238
180 NORMAL NEWBORN 129 0.0237
181 GASTROINTESTINAL TOXICITY 114 0.0237
182 WHEEZING 1405 0.0237
183 LIVER FUNCTION TEST INCREASED 501 0.0233
184 SPINAL FUSION SURGERY 94 0.0231
185 DRUG TOLERANCE 116 0.0229
186 INJURY 1598 0.0227
187 ANGIOCENTRIC LYMPHOMA 11 0.0224
188 STOMATITIS 1333 0.0220
189 JOINT STIFFNESS 575 0.0219
190 CONGENITAL ANOMALY 169 0.0218
191 INFLAMMATION 1104 0.0214
192 HYPOPNOEA 74 0.0213
193 DISCONTINUED PRODUCT ADMINISTERED 7 0.0213
194 MUSCULOSKELETAL PAIN 1107 0.0211
195 PARATHYROID DISORDER 17 0.0209
196 POLYARTHRITIS 107 0.0203
197 THERAPY NON-RESPONDER 906 0.0201
198 HEPATIC ENZYME DECREASED 9 0.0200
199 GENERAL PHYSICAL HEALTH DETERIORATION 2291 0.0198
200 LUNG DISORDER 961 0.0196
201 INTENTIONAL PRODUCT USE ISSUE 1701 0.0194
202 FAECAL CALPROTECTIN ABNORMAL 8 0.0193
203 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 25 0.0190
204 EXPOSURE DURING PREGNANCY 1177 0.0189
205 OEDEMA 1026 0.0189
206 TENOSYNOVITIS 52 0.0188
207 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 322 0.0188
208 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 11 0.0186
209 ALVEOLAR PROTEINOSIS 11 0.0186
210 HEPATIC CIRRHOSIS 348 0.0185
211 ALLERGY TO CHEMICALS 23 0.0185
212 ABDOMINAL DISCOMFORT 3073 0.0183
213 BUTTERFLY RASH 18 0.0178
214 DELIRIUM 616 0.0177
215 CYTOMEGALOVIRUS CHORIORETINITIS 34 0.0174
216 EPILEPSY 532 0.0174
217 PULMONARY TOXICITY 122 0.0172
218 VULVAL ABSCESS 7 0.0170
219 DIVERTICULITIS INTESTINAL PERFORATED 6 0.0168
220 PHAEOHYPHOMYCOSIS 8 0.0167
221 ROAD TRAFFIC ACCIDENT 690 0.0165
222 HYPERFERRITINAEMIA 7 0.0162
223 JOINT SURGERY 7 0.0161
224 BRONCHIECTASIS 106 0.0157
225 LIVER DISORDER 696 0.0157
226 OPHTHALMIC HERPES SIMPLEX 9 0.0156
227 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 744 0.0155
228 ILL-DEFINED DISORDER 939 0.0154
229 ALOPECIA 3030 0.0154
230 LIP ULCERATION 18 0.0154
231 ADVERSE REACTION 204 0.0154
232 BONE INFARCTION 7 0.0154
233 HYPERSENSITIVITY 2850 0.0153
234 SKIN NEOPLASM EXCISION 12 0.0153
235 PHONOPHOBIA 7 0.0152
236 SLEEP DISORDER 1073 0.0152
237 MULTIPLE-DRUG RESISTANCE 47 0.0151
238 ECZEMA HERPETICUM 7 0.0151
239 EROSIVE DUODENITIS 12 0.0150
240 DISABILITY 292 0.0148
241 CHRONIC SPONTANEOUS URTICARIA 17 0.0147
242 PARATHYROIDECTOMY 7 0.0146
243 INTERLEUKIN LEVEL INCREASED 8 0.0145
244 PNEUMOMEDIASTINUM 26 0.0144
245 DRUG-INDUCED LIVER INJURY 451 0.0144
246 FAECAL CALPROTECTIN INCREASED 45 0.0142
247 PLEURITIC PAIN 39 0.0141
248 PLAGIOCEPHALY 7 0.0140
249 MICROGNATHIA 7 0.0140
250 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 105 0.0140
251 LARYNGEAL DISORDER 10 0.0139
252 CREPITATIONS 41 0.0138
253 PRURITUS ALLERGIC 16 0.0137
254 NERVE BLOCK 8 0.0137
255 GROWTH RETARDATION 40 0.0136
256 SPINAL STENOSIS 56 0.0136
257 JUVENILE IDIOPATHIC ARTHRITIS 33 0.0135
258 NEUROENDOCRINE CARCINOMA OF THE SKIN 13 0.0133
259 LAPAROTOMY 6 0.0131
260 PREGNANCY 262 0.0131
261 STEATOHEPATITIS 7 0.0131
262 OBSTRUCTIVE SLEEP APNOEA SYNDROME 19 0.0130
263 CEREBRAL VENOUS SINUS THROMBOSIS 11 0.0130
264 NUTRITIONAL CONDITION ABNORMAL 9 0.0129
265 RASH VESICULAR 61 0.0126
266 CYTOMEGALOVIRUS COLITIS 29 0.0126
267 RHEUMATOID FACTOR INCREASED 14 0.0125
268 GASTROINTESTINAL DISORDER 1123 0.0125
269 SKIN NECROSIS 65 0.0125
270 BRONCHIAL HYPERREACTIVITY 15 0.0125
271 DIFFUSE ALOPECIA 23 0.0124
272 FREQUENT BOWEL MOVEMENTS 334 0.0124
273 DRY MOUTH 1003 0.0123
274 C-REACTIVE PROTEIN DECREASED 8 0.0123
275 NEOPLASM SKIN 19 0.0122
276 ENTHESOPATHY 19 0.0121
277 PRODUCT USE ISSUE 2218 0.0118
278 NONINFECTIVE GINGIVITIS 17 0.0117
279 ANTINUCLEAR ANTIBODY POSITIVE 38 0.0117
280 PNEUMONIA CRYPTOCOCCAL 11 0.0116
281 COLITIS ULCERATIVE 516 0.0115
282 SUSPECTED OFF LABEL USE 52 0.0115
283 EXTRADURAL ABSCESS 9 0.0115
284 HEPATITIS 290 0.0113
285 LOSS OF THERAPEUTIC RESPONSE 36 0.0113
286 BLOOD IRON ABNORMAL 11 0.0113
287 HYPERTRANSAMINASAEMIA 78 0.0112
288 JOINT ARTHROPLASTY 20 0.0112
289 SACROILIITIS 21 0.0111
290 EAR INFECTION 293 0.0110
291 OSTEOPOROSIS 451 0.0110
292 NECROTISING RETINITIS 7 0.0109
293 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 29 0.0109
294 INFECTION 1578 0.0109
295 SINUSITIS 1106 0.0108
296 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 762 0.0107
297 ADVERSE EVENT 983 0.0107
298 DERMATOMYOSITIS 27 0.0106
299 DYSPEPSIA 1038 0.0105
300 PERIPHERAL SWELLING 1623 0.0105
301 POUCHITIS 9 0.0105
302 HYPOAESTHESIA 1555 0.0104
303 HYPOAESTHESIA EYE 6 0.0102
304 THYROID NEOPLASM 28 0.0101
305 CONTUSION 976 0.0101
306 MIGRAINE 964 0.0101
307 CONDITION AGGRAVATED 3064 0.0101
308 RHINITIS 80 0.0099
309 WEIGHT FLUCTUATION 103 0.0098
310 MEAN CELL HAEMOGLOBIN DECREASED 18 0.0098
311 PNEUMONIA PSEUDOMONAL 15 0.0098
312 BIOPSY 9 0.0097
313 PAROSMIA 73 0.0097
314 HYPERTENSION 2017 0.0095
315 EPSTEIN-BARR VIRUS TEST POSITIVE 6 0.0095
316 ADVERSE DRUG REACTION 849 0.0094
317 MEDICATION ERROR 523 0.0094
318 INTESTINAL ANASTOMOSIS 6 0.0093
319 GINGIVAL PAIN 74 0.0093
320 VASCULITIC RASH 7 0.0091
321 HIRSUTISM 12 0.0090
322 JUGULAR VEIN THROMBOSIS 16 0.0090
323 AMNESIA 584 0.0090
324 MYOSITIS 79 0.0088
325 EAR PAIN 171 0.0088
326 KERATOACANTHOMA 6 0.0088
327 CONFUSIONAL STATE 1416 0.0088
328 RETINAL TOXICITY 9 0.0087
329 CARDIAC MURMUR 75 0.0087
330 SEROTONIN SYNDROME 166 0.0086
331 URTICARIA 1427 0.0085
332 SYNOVIAL CYST 39 0.0084
333 CYTOMEGALOVIRUS INFECTION REACTIVATION 37 0.0084
334 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 139 0.0082
335 HEPATOTOXICITY 182 0.0082
336 ULCER 129 0.0081
337 IMPAIRED WORK ABILITY 173 0.0081
338 ARTHRITIS BACTERIAL 33 0.0080
339 UPPER RESPIRATORY TRACT INFECTION 371 0.0080
340 RASH 3455 0.0079
341 BREATH SOUNDS ABNORMAL 39 0.0079
342 INFECTION REACTIVATION 9 0.0079
343 NASOPHARYNGITIS 1443 0.0078
344 OSTEOCHONDROSIS 9 0.0078
345 VARICELLA ZOSTER VIRUS INFECTION 16 0.0077
346 NECK PAIN 431 0.0077
347 ORAL DISCOMFORT 107 0.0077
348 GASTROOESOPHAGEAL REFLUX DISEASE 619 0.0077
349 ARTHRITIS 597 0.0076
350 PNEUMOCYSTIS JIROVECII INFECTION 9 0.0075
351 HYDROCELE 8 0.0075
352 OSTEOPOROTIC FRACTURE 14 0.0073
353 MEAN PLATELET VOLUME DECREASED 6 0.0072
354 JOINT EFFUSION 49 0.0071
355 RECTAL HAEMORRHAGE 304 0.0071
356 HAEMANGIOMA OF LIVER 7 0.0069
357 ACTINIC KERATOSIS 18 0.0069
358 ARTHRALGIA 2839 0.0068
359 BK VIRUS INFECTION 23 0.0068
360 LYMPHOPROLIFERATIVE DISORDER 20 0.0068
361 THERAPEUTIC RESPONSE DECREASED 412 0.0068
362 MUSCULAR WEAKNESS 765 0.0067
363 JOINT LOCK 19 0.0067
364 RESPIRATORY DISORDER 200 0.0067
365 RHINOVIRUS INFECTION 26 0.0067
366 PYODERMA GANGRENOSUM 24 0.0067
367 WEIGHT INCREASED 1493 0.0067
368 ASTHMA 732 0.0065
369 JOINT INJURY 136 0.0064
370 MEMORY IMPAIRMENT 874 0.0064
371 PRODUCT USE IN UNAPPROVED INDICATION 1550 0.0062
372 LUNG ABSCESS 13 0.0062
373 COVID-19 PNEUMONIA 73 0.0062
374 BACK DISORDER 100 0.0061
375 HYPERCALCAEMIA 75 0.0061
376 SUPERINFECTION 9 0.0060
377 PAIN 3668 0.0060
378 DECREASED APPETITE 1384 0.0060
379 OPPORTUNISTIC INFECTION 11 0.0059
380 URINARY TRACT INFECTION BACTERIAL 15 0.0059
381 PUSTULE 14 0.0059
382 ILEOSTOMY 15 0.0059
383 ABDOMINAL PAIN UPPER 1209 0.0059
384 NOCARDIOSIS 15 0.0059
385 GENERAL SYMPTOM 43 0.0057
386 EAR SWELLING 12 0.0057
387 ENTEROCOCCAL BACTERAEMIA 6 0.0057
388 ATYPICAL MYCOBACTERIAL INFECTION 8 0.0057
389 PELVIC VENOUS THROMBOSIS 8 0.0056
390 BASAL CELL CARCINOMA 87 0.0056
391 THROMBOCYTOSIS 20 0.0055
392 GASTRIC DISORDER 187 0.0054
393 METABOLIC ACIDOSIS 174 0.0054
394 LISTERIOSIS 6 0.0054
395 IMPAIRED QUALITY OF LIFE 76 0.0053
396 PNEUMOCYSTIS JIROVECII PNEUMONIA 53 0.0053
397 OEDEMA PERIPHERAL 636 0.0052
398 BRONCHOPULMONARY ASPERGILLOSIS 40 0.0052
399 PAIN IN EXTREMITY 1519 0.0052
400 GLOMERULONEPHRITIS MEMBRANOUS 6 0.0051
401 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 9 0.0051
402 CENTRAL NERVOUS SYSTEM LYMPHOMA 7 0.0051
403 CHEST PAIN 931 0.0050
404 NASAL ULCER 8 0.0050
405 GLOMERULAR FILTRATION RATE ABNORMAL 7 0.0049
406 PAIN IN JAW 139 0.0049
407 ANAPHYLACTIC REACTION 271 0.0049
408 PARAESTHESIA 769 0.0049
409 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 267 0.0049
410 COLITIS MICROSCOPIC 23 0.0049
411 IGA NEPHROPATHY 8 0.0048
412 PHYSICAL DISABILITY 21 0.0047
413 SERUM FERRITIN INCREASED 25 0.0047
414 MUSCLE SPASMS 863 0.0047
415 SPINAL DISORDER 44 0.0046
416 DEPRESSION 1044 0.0046
417 GAIT DISTURBANCE 875 0.0046
418 OFF LABEL USE 3987 0.0045
419 ENTEROCOCCAL INFECTION 22 0.0045
420 HISTOPLASMOSIS 8 0.0045
421 DEFORMITY 42 0.0045
422 HEPATIC STEATOSIS 83 0.0045
423 SHOULDER ARTHROPLASTY 12 0.0045
424 FATIGUE 3468 0.0044
425 STENOTROPHOMONAS INFECTION 6 0.0044
426 PERIARTHRITIS 10 0.0044
427 PNEUMONIA VIRAL 14 0.0044
428 DRUG SPECIFIC ANTIBODY 6 0.0044
429 UNDERDOSE 319 0.0044
430 SQUAMOUS CELL CARCINOMA OF SKIN 26 0.0043
431 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 10 0.0043
432 CRYPTOCOCCOSIS 7 0.0043
433 ADRENAL INSUFFICIENCY 52 0.0043
434 PNEUMONIA 1383 0.0043
435 FLANK PAIN 40 0.0043
436 PAPILLOMA VIRAL INFECTION 7 0.0042
437 DUODENITIS 13 0.0042
438 INFLAMMATORY MARKER INCREASED 21 0.0042
439 TENDERNESS 44 0.0042
440 NODULE 55 0.0042
441 FURUNCLE 33 0.0042
442 RADIUS FRACTURE 10 0.0042
443 ATELECTASIS 40 0.0041
444 SEBORRHOEIC KERATOSIS 6 0.0041
445 DRUG ERUPTION 73 0.0041
446 LOWER RESPIRATORY TRACT CONGESTION 7 0.0041
447 BLOOD PRESSURE DIASTOLIC INCREASED 19 0.0041
448 VISUAL IMPAIRMENT 510 0.0041
449 INFECTION SUSCEPTIBILITY INCREASED 9 0.0041
450 PYELONEPHRITIS ACUTE 8 0.0041
451 CYTOMEGALOVIRUS VIRAEMIA 18 0.0040
452 DRUG INEFFECTIVE 5295 0.0040
453 INFECTIOUS MONONUCLEOSIS 9 0.0040
454 MUSCLE SPASTICITY 49 0.0040
455 SKIN ULCER 103 0.0040
456 LYMPHOCYTE COUNT INCREASED 13 0.0040
457 EMBOLISM VENOUS 12 0.0040
458 ASPARTATE AMINOTRANSFERASE ABNORMAL 6 0.0039
459 CHOLANGITIS SCLEROSING 8 0.0039
460 TUBULOINTERSTITIAL NEPHRITIS 73 0.0039
461 MEAN CELL VOLUME DECREASED 6 0.0039
462 IMMUNODEFICIENCY 58 0.0039
463 DIVERTICULAR PERFORATION 8 0.0039
464 CUTANEOUS VASCULITIS 14 0.0038
465 RASH PRURITIC 205 0.0038
466 DERMATITIS ACNEIFORM 23 0.0038
467 SKIN REACTION 53 0.0038
468 ABSCESS LIMB 16 0.0038
469 PNEUMONIA LEGIONELLA 6 0.0037
470 PYREXIA 1295 0.0037
471 PRODUCT QUALITY ISSUE 508 0.0037
472 VOMITING 1752 0.0037
473 ULCERATIVE KERATITIS 10 0.0036
474 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 6 0.0036
475 ABDOMINAL PAIN 826 0.0035
476 INSOMNIA 934 0.0035
477 CERVICAL SPINAL STENOSIS 6 0.0035
478 INJECTION SITE REACTION 239 0.0035
479 UVEITIS 47 0.0035
480 FINE MOTOR SKILL DYSFUNCTION 10 0.0035
481 CONJUNCTIVITIS 64 0.0034
482 WHITE BLOOD CELL COUNT INCREASED 132 0.0034
483 CYTOMEGALOVIRUS INFECTION 57 0.0034
484 HEADACHE 2148 0.0034
485 ALOPECIA AREATA 6 0.0034
486 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 17 0.0034
487 CYTOMEGALOVIRUS TEST POSITIVE 6 0.0034
488 LABORATORY TEST ABNORMAL 99 0.0034
489 OPHTHALMIC HERPES ZOSTER 6 0.0033
490 LUNG ADENOCARCINOMA 10 0.0033
491 MALAISE 1457 0.0033
492 DIARRHOEA HAEMORRHAGIC 31 0.0033
493 BRONCHITIS 245 0.0033
494 SKIN MASS 22 0.0033
495 PANCREATITIS 174 0.0033
496 ESCHERICHIA INFECTION 27 0.0033
497 SOFT TISSUE INFECTION 6 0.0033
498 INFLAMMATORY BOWEL DISEASE 32 0.0033
499 PSEUDOMONAS INFECTION 28 0.0033
500 PARADOXICAL DRUG REACTION 12 0.0033
501 DUODENAL ULCER 23 0.0033
502 CLOSTRIDIUM DIFFICILE COLITIS 34 0.0032
503 ADENOCARCINOMA OF COLON 6 0.0032
504 SYMPTOM RECURRENCE 19 0.0032
505 FEELING HOT 194 0.0032
506 HEPATITIS B REACTIVATION 10 0.0031
507 TEMPERATURE REGULATION DISORDER 7 0.0031
508 RETINAL VEIN OCCLUSION 9 0.0031
509 INTERSTITIAL LUNG DISEASE 151 0.0031
510 ESCHERICHIA URINARY TRACT INFECTION 13 0.0031
511 WEIGHT DECREASED 842 0.0030
512 SPINAL PAIN 35 0.0030
513 ENTERITIS 19 0.0030
514 ANAL ABSCESS 16 0.0030
515 OSTEOPENIA 45 0.0030
516 COLITIS ISCHAEMIC 20 0.0030
517 PRURITUS 1136 0.0030
518 ECTOPIC PREGNANCY 9 0.0029
519 AUTOIMMUNE HAEMOLYTIC ANAEMIA 10 0.0029
520 HAEMATOCHEZIA 161 0.0029
521 PSORIASIS 379 0.0029
522 ORAL CANDIDIASIS 38 0.0029
523 SWOLLEN TONGUE 90 0.0029
524 EPSTEIN-BARR VIRUS INFECTION 18 0.0029
525 TACHYCARDIA 254 0.0029
526 IRIDOCYCLITIS 9 0.0028
527 SUICIDE ATTEMPT 171 0.0028
528 HEPATIC ENZYME ABNORMAL 14 0.0028
529 NEOPLASM MALIGNANT 187 0.0028
530 ASTHENIA 1044 0.0028
531 ACCIDENTAL OVERDOSE 101 0.0028
532 THERAPY PARTIAL RESPONDER 43 0.0028
533 APPENDICITIS PERFORATED 7 0.0028
534 SPINAL COLUMN STENOSIS 13 0.0027
535 BLOOD PRESSURE DIASTOLIC ABNORMAL 7 0.0027
536 IMMOBILE 12 0.0027
537 ASPERGILLUS INFECTION 18 0.0027
538 DEEP VEIN THROMBOSIS 178 0.0027
539 LUMBAR SPINAL STENOSIS 8 0.0027
540 ENDOMETRIAL CANCER 6 0.0027
541 IMMUNOSUPPRESSION 24 0.0027
542 BREAST CANCER STAGE I 25 0.0027
543 APPENDICITIS 25 0.0027
544 ABDOMINAL DISTENSION 278 0.0027
545 LOSS OF EMPLOYMENT 8 0.0026
546 RED CELL DISTRIBUTION WIDTH INCREASED 11 0.0026
547 URINE ABNORMALITY 12 0.0026
548 IRON DEFICIENCY ANAEMIA 24 0.0026
549 LARGE INTESTINAL ULCER 7 0.0026
550 DIARRHOEA 1664 0.0026
551 DIZZINESS 1284 0.0026
552 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 75 0.0026
553 INTENTIONAL OVERDOSE 164 0.0026
554 CYTOPENIA 31 0.0025
555 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 6 0.0025
556 OESOPHAGEAL CANDIDIASIS 10 0.0025
557 FAILURE TO THRIVE 13 0.0025
558 LIMB OPERATION 12 0.0025
559 ASPIRATION 27 0.0025
560 HERPES SIMPLEX 16 0.0025
561 LEUKOPENIA 123 0.0025
562 DEMYELINATION 10 0.0024
563 CARTILAGE INJURY 6 0.0024
564 BONE DENSITY ABNORMAL 9 0.0024
565 INCORRECT PRODUCT ADMINISTRATION DURATION 52 0.0024
566 CHRONIC SINUSITIS 9 0.0024
567 PNEUMONIA BACTERIAL 22 0.0024
568 PHOTOPHOBIA 45 0.0024
569 DRUG USE DISORDER 20 0.0024
570 DYSPNOEA 1328 0.0023
571 LYMPHADENOPATHY 83 0.0023
572 INCREASED UPPER AIRWAY SECRETION 12 0.0023
573 DIFFUSE LARGE B-CELL LYMPHOMA 18 0.0023
574 DRUG SPECIFIC ANTIBODY PRESENT 15 0.0023
575 COLECTOMY 13 0.0023
576 PROSTATITIS 7 0.0023
577 ERYTHEMA NODOSUM 8 0.0023
578 BACTERAEMIA 27 0.0023
579 NAUSEA 1787 0.0023
580 SKIN PAPILLOMA 9 0.0022
581 QUALITY OF LIFE DECREASED 30 0.0022
582 NIGHTMARE 77 0.0022
583 ORGANISING PNEUMONIA 11 0.0022
584 ANXIETY 626 0.0022
585 HERPES ZOSTER 126 0.0022
586 TREATMENT NONCOMPLIANCE 119 0.0022
587 CYSTIC FIBROSIS 12 0.0022
588 SERUM SICKNESS 6 0.0022
589 PURULENT DISCHARGE 9 0.0021
590 FLUID RETENTION 105 0.0021
591 WOUND COMPLICATION 7 0.0020
592 VULVOVAGINAL MYCOTIC INFECTION 8 0.0020
593 FOETAL EXPOSURE DURING PREGNANCY 164 0.0020
594 AUTOIMMUNE HEPATITIS 14 0.0020
595 INTERVERTEBRAL DISC PROTRUSION 44 0.0020
596 MENINGITIS ASEPTIC 9 0.0020
597 SEPTIC SHOCK 87 0.0020
598 PULMONARY EMBOLISM 189 0.0020
599 PAPULE 14 0.0020
600 HAEMOGLOBIN INCREASED 9 0.0020
601 NEPHROPATHY TOXIC 22 0.0020
602 BOWEL MOVEMENT IRREGULARITY 15 0.0020
603 RESPIRATORY TRACT INFECTION 51 0.0020
604 RECTAL CANCER 6 0.0020
605 ORAL HERPES 38 0.0019
606 FEELING JITTERY 37 0.0019
607 ASPARTATE AMINOTRANSFERASE INCREASED 103 0.0019
608 POSTOPERATIVE WOUND INFECTION 13 0.0019
609 MATERNAL EXPOSURE BEFORE PREGNANCY 13 0.0019
610 FRACTURE 36 0.0019
611 SENSITIVITY TO WEATHER CHANGE 10 0.0019
612 FOOT FRACTURE 36 0.0019
613 CANDIDA INFECTION 32 0.0019
614 LOWER GASTROINTESTINAL HAEMORRHAGE 14 0.0019
615 DISEASE RECURRENCE 90 0.0019
616 PULMONARY MASS 28 0.0019
617 DIVERTICULITIS 52 0.0019
618 PULMONARY TUBERCULOSIS 8 0.0019
619 MOUTH ULCERATION 39 0.0018
620 GASTROENTERITIS 27 0.0018
621 STAPHYLOCOCCAL BACTERAEMIA 8 0.0018
622 RENAL CELL CARCINOMA 9 0.0018
623 HYPOGAMMAGLOBULINAEMIA 12 0.0018
624 LISTLESS 6 0.0018
625 OTITIS MEDIA 6 0.0018
626 WHEELCHAIR USER 8 0.0018
627 ALANINE AMINOTRANSFERASE INCREASED 110 0.0018
628 MALIGNANT MELANOMA 24 0.0018
629 POTENTIATING DRUG INTERACTION 6 0.0018
630 GASTROINTESTINAL INFECTION 16 0.0018
631 TINNITUS 82 0.0018
632 FEEDING DISORDER 36 0.0018
633 CYST 22 0.0018
634 COLITIS 67 0.0018
635 B-CELL LYMPHOMA 6 0.0018
636 NEUTROPHIL COUNT INCREASED 18 0.0018
637 SPINAL FRACTURE 35 0.0017
638 TENDONITIS 27 0.0017
639 BLOOD CREATININE INCREASED 113 0.0017
640 LARGE INTESTINE PERFORATION 12 0.0017
641 MOVEMENT DISORDER 55 0.0017
642 LIMB DISCOMFORT 53 0.0017
643 DEFAECATION URGENCY 12 0.0017
644 SQUAMOUS CELL CARCINOMA 16 0.0017
645 PLATELET COUNT INCREASED 22 0.0017
646 VIRAL UPPER RESPIRATORY TRACT INFECTION 8 0.0017
647 PELVIC FRACTURE 13 0.0017
648 ECZEMA 86 0.0016
649 PNEUMOTHORAX 26 0.0016
650 SCAR 28 0.0016
651 IMMUNE-MEDIATED ENTEROCOLITIS 6 0.0016
652 BODY TEMPERATURE INCREASED 33 0.0016
653 FOOT OPERATION 8 0.0016
654 MUCOUS STOOLS 8 0.0016
655 ERYSIPELAS 8 0.0016
656 HAIR GROWTH ABNORMAL 11 0.0016
657 SNORING 6 0.0016
658 ACUTE KIDNEY INJURY 242 0.0016
659 DYSLIPIDAEMIA 8 0.0016
660 CACHEXIA 8 0.0016
661 LYMPHOMA 24 0.0016
662 DRUG INTERACTION 243 0.0015
663 CATARACT 91 0.0015
664 PNEUMONIA FUNGAL 6 0.0015
665 SKIN INFECTION 17 0.0015
666 HOSPITALISATION 232 0.0015
667 EXPOSURE VIA BREAST MILK 6 0.0015
668 UTERINE LEIOMYOMA 11 0.0015
669 MASS 21 0.0015
670 SKIN ABRASION 7 0.0015
671 HAEMATOTOXICITY 14 0.0015
672 SUBCUTANEOUS ABSCESS 7 0.0015
673 PEMPHIGOID 11 0.0015
674 GALLBLADDER DISORDER 26 0.0015
675 DEAFNESS 38 0.0015
676 GASTROINTESTINAL PERFORATION 6 0.0014
677 SKIN DISORDER 48 0.0014
678 DERMATITIS 30 0.0014
679 VERTIGO 87 0.0014
680 CLOSTRIDIUM DIFFICILE INFECTION 31 0.0014
681 APNOEA 11 0.0014
682 MULTIPLE ORGAN DYSFUNCTION SYNDROME 40 0.0014
683 OVARIAN CANCER 13 0.0014
684 INJECTION SITE INFLAMMATION 7 0.0014
685 CHOLECYSTECTOMY 16 0.0014
686 MOUTH SWELLING 8 0.0014
687 HYSTERECTOMY 12 0.0014
688 MUSCULOSKELETAL DISORDER 26 0.0014
689 PARONYCHIA 6 0.0014
690 DEVICE RELATED INFECTION 21 0.0014
691 RED BLOOD CELL COUNT DECREASED 39 0.0014
692 LYMPHOCYTE COUNT DECREASED 24 0.0014
693 BLOOD PRESSURE DIASTOLIC DECREASED 10 0.0014
694 DRY EYE 67 0.0013
695 ANAL INCONTINENCE 12 0.0013
696 LARGE INTESTINE POLYP 9 0.0013
697 CELLULITIS 65 0.0013
698 VASCULITIS 15 0.0013
699 GASTROINTESTINAL INFLAMMATION 10 0.0013
700 LYMPHOPENIA 18 0.0013
701 SINUS CONGESTION 17 0.0013
702 DRUG RESISTANCE 32 0.0012
703 BLOOD CREATINE PHOSPHOKINASE INCREASED 35 0.0012
704 DIABETES MELLITUS 92 0.0012
705 EMBOLISM 10 0.0012
706 COVID-19 210 0.0012
707 DERMATITIS ALLERGIC 15 0.0012
708 PLEURISY 7 0.0012
709 MYELODYSPLASTIC SYNDROME 17 0.0012
710 INTENTIONAL PRODUCT MISUSE 102 0.0012
711 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
712 FOETAL DEATH 6 0.0012
713 ACUTE MYOCARDIAL INFARCTION 34 0.0012
714 THROMBOCYTOPENIA 128 0.0011
715 EOSINOPHILIA 20 0.0011
716 SMALL INTESTINAL OBSTRUCTION 14 0.0011
717 ACUTE RESPIRATORY DISTRESS SYNDROME 20 0.0011
718 BODY HEIGHT DECREASED 12 0.0011
719 BONE DENSITY DECREASED 35 0.0011
720 CARDIOVASCULAR DISORDER 28 0.0011
721 BLOOD IRON DECREASED 13 0.0011
722 LUNG INFECTION 17 0.0011
723 HYPERLIPIDAEMIA 13 0.0011
724 RASH MACULO-PAPULAR 24 0.0011
725 HYPERTENSIVE CRISIS 12 0.0011
726 KIDNEY INFECTION 21 0.0011
727 BLOOD TEST ABNORMAL 15 0.0011
728 MUCOSAL INFLAMMATION 27 0.0010
729 STAPHYLOCOCCAL INFECTION 34 0.0010
730 HYPOALBUMINAEMIA 8 0.0010
731 BODY TEMPERATURE DECREASED 10 0.0010
732 FACIAL PAIN 9 0.0010
733 OESOPHAGITIS 11 0.0010
734 LIVER FUNCTION TEST ABNORMAL 29 0.0010
735 PRODUCT COMPLAINT 25 0.0010
736 ANKYLOSING SPONDYLITIS 13 0.0010
737 RETINAL HAEMORRHAGE 7 0.0010
738 DYSGEUSIA 73 0.0010
739 UROSEPSIS 9 0.0010
740 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 8 0.0010
741 MYOCARDIAL ISCHAEMIA 11 0.0010
742 PRE-EXISTING CONDITION IMPROVED 6 0.0010
743 DISEASE PROGRESSION 113 0.0010
744 HYPOKALAEMIA 44 0.0010
745 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
746 HAEMOGLOBIN DECREASED 96 0.0009
747 RESPIRATORY FAILURE 68 0.0009
748 PYELONEPHRITIS 8 0.0009
749 PNEUMONITIS 25 0.0009
750 DECREASED IMMUNE RESPONSIVENESS 9 0.0009
751 POLYP 6 0.0009
752 FUNGAL INFECTION 30 0.0009
753 TENDON RUPTURE 11 0.0009
754 INTESTINAL PERFORATION 10 0.0009
755 REBOUND EFFECT 10 0.0009
756 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 159 0.0009
757 NEPHROTIC SYNDROME 6 0.0009
758 TRANSPLANT REJECTION 7 0.0009
759 SEPSIS 97 0.0009
760 UNEVALUABLE EVENT 65 0.0009
761 PANCYTOPENIA 48 0.0009
762 OSTEONECROSIS 28 0.0009
763 SKIN LESION 23 0.0008
764 POLYNEUROPATHY 10 0.0008
765 GASTROENTERITIS VIRAL 15 0.0008
766 OCULAR HYPERAEMIA 39 0.0008
767 FACIAL PARALYSIS 7 0.0008
768 WHITE BLOOD CELL COUNT DECREASED 88 0.0008
769 COLON CANCER 12 0.0008
770 MALNUTRITION 9 0.0008
771 RESPIRATORY SYNCYTIAL VIRUS INFECTION 7 0.0008
772 SWELLING FACE 52 0.0008
773 HYPOCALCAEMIA 15 0.0008
774 TENDON PAIN 6 0.0008
775 POOR QUALITY SLEEP 17 0.0008
776 DERMATITIS CONTACT 9 0.0008
777 SCAB 9 0.0008
778 EAR DISCOMFORT 8 0.0008
779 HAEMORRHOIDS 15 0.0008
780 PALPITATIONS 90 0.0008
781 HIDRADENITIS 7 0.0008
782 FALL 255 0.0008
783 THROMBOSIS 61 0.0008
784 CEREBROVASCULAR ACCIDENT 128 0.0008
785 OVERDOSE 163 0.0008
786 ERYTHEMA 153 0.0007
787 BLOOD BILIRUBIN INCREASED 20 0.0007
788 THERAPEUTIC RESPONSE UNEXPECTED 33 0.0007
789 ISCHAEMIC STROKE 13 0.0007
790 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 38 0.0007
791 GLAUCOMA 14 0.0007
792 EYE PAIN 41 0.0007
793 EYE SWELLING 27 0.0007
794 CYSTITIS 23 0.0007
795 OSTEOMYELITIS 13 0.0007
796 PANCREATITIS ACUTE 16 0.0007
797 DISSEMINATED INTRAVASCULAR COAGULATION 10 0.0007
798 ACUTE MYELOID LEUKAEMIA 11 0.0007
799 MYOCARDITIS 8 0.0007
800 SKIN CANCER 15 0.0007
801 NEOPLASM 8 0.0007
802 DRUG LEVEL DECREASED 7 0.0007
803 TOOTH ABSCESS 7 0.0007
804 SUBARACHNOID HAEMORRHAGE 7 0.0007
805 SPINAL OSTEOARTHRITIS 6 0.0007
806 LUNG NEOPLASM MALIGNANT 28 0.0007
807 EYE DISCHARGE 7 0.0007
808 HEART RATE IRREGULAR 15 0.0007
809 INTESTINAL OBSTRUCTION 25 0.0007
810 HAEMATOCRIT DECREASED 13 0.0007
811 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
812 NO ADVERSE EVENT 117 0.0006
813 BACTERIAL INFECTION 12 0.0006
814 BACK PAIN 147 0.0006
815 NEPHROLITHIASIS 29 0.0006
816 GAMMA-GLUTAMYLTRANSFERASE INCREASED 14 0.0006
817 TRANSAMINASES INCREASED 14 0.0006
818 HEPATIC CYTOLYSIS 8 0.0006
819 EYE IRRITATION 36 0.0006
820 ACUTE RESPIRATORY FAILURE 12 0.0006
821 CARDIAC FAILURE 50 0.0006
822 BLOOD TRIGLYCERIDES INCREASED 11 0.0006
823 HIATUS HERNIA 8 0.0006
824 DIPLOPIA 16 0.0006
825 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
826 TOOTH INFECTION 8 0.0006
827 COAGULOPATHY 10 0.0006
828 CYTOKINE RELEASE SYNDROME 12 0.0006
829 HAEMATURIA 20 0.0006
830 THYROID DISORDER 9 0.0006
831 CHOLELITHIASIS 19 0.0006
832 LOCALISED INFECTION 14 0.0006
833 PLEURAL EFFUSION 35 0.0006
834 METASTASES TO LIVER 10 0.0006
835 HERNIA 11 0.0006
836 PHARYNGITIS 7 0.0006
837 HYPOTHYROIDISM 18 0.0006
838 RENAL DISORDER 26 0.0006
839 LEUKOCYTOSIS 10 0.0006
840 BIPOLAR DISORDER 6 0.0006
841 DRUG EFFECT INCOMPLETE 20 0.0006
842 ABORTION SPONTANEOUS 22 0.0005
843 NEOPLASM PROGRESSION 19 0.0005
844 VIRAL INFECTION 18 0.0005
845 ORAL PAIN 12 0.0005
846 URINARY TRACT INFECTION 91 0.0005
847 GASTRITIS 14 0.0005
848 PERITONITIS 11 0.0005
849 NEUTROPENIA 72 0.0005
850 MUSCULOSKELETAL DISCOMFORT 9 0.0005
851 ANGIOEDEMA 23 0.0005
852 PERICARDIAL EFFUSION 12 0.0005
853 SPLENOMEGALY 6 0.0005
854 RESPIRATORY DISTRESS 14 0.0005
855 CHOLECYSTITIS 6 0.0005
856 LOSS OF CONSCIOUSNESS 64 0.0005
857 HEPATIC FAILURE 15 0.0005
858 ANAEMIA 94 0.0005
859 PULMONARY HYPERTENSION 10 0.0005
860 GASTROINTESTINAL HAEMORRHAGE 40 0.0005
861 LIMB INJURY 13 0.0005
862 SKIN FISSURES 9 0.0005
863 SARS-COV-2 TEST POSITIVE 6 0.0005
864 TRANSIENT ISCHAEMIC ATTACK 15 0.0004
865 SOMNOLENCE 89 0.0004
866 ACUTE HEPATIC FAILURE 6 0.0004
867 SHOCK 10 0.0004
868 MUSCLE TWITCHING 10 0.0004
869 HYPOMAGNESAEMIA 6 0.0004
870 PHOTOSENSITIVITY REACTION 7 0.0004
871 ACNE 32 0.0004
872 BREAST CANCER 39 0.0004
873 BURNING SENSATION 29 0.0004
874 PRODUCT PRESCRIBING ISSUE 9 0.0004
875 HYPERGLYCAEMIA 15 0.0004
876 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
877 HAEMORRHAGE 42 0.0004
878 ATRIAL FIBRILLATION 38 0.0004
879 RIB FRACTURE 8 0.0004
880 ANGINA PECTORIS 11 0.0004
881 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
882 RESPIRATORY TRACT CONGESTION 6 0.0004
883 PREMATURE DELIVERY 6 0.0004
884 DYSSTASIA 11 0.0004
885 BONE PAIN 22 0.0004
886 PRODUCT DISPENSING ERROR 8 0.0004
887 MYALGIA 62 0.0004
888 TOXICITY TO VARIOUS AGENTS 60 0.0004
889 HYPOXIA 12 0.0003
890 INFLUENZA 38 0.0003
891 MYELOSUPPRESSION 12 0.0003
892 THERAPEUTIC RESPONSE SHORTENED 11 0.0003
893 DEATH 285 0.0003
894 LIP SWELLING 11 0.0003
895 BONE DISORDER 6 0.0003
896 CEREBRAL INFARCTION 8 0.0003
897 FEMUR FRACTURE 10 0.0003
898 PLATELET COUNT DECREASED 34 0.0003
899 HOT FLUSH 24 0.0003
900 NEUROPATHY PERIPHERAL 30 0.0003
901 CARDIAC ARREST 26 0.0003
902 OROPHARYNGEAL PAIN 29 0.0003
903 CEREBRAL HAEMORRHAGE 11 0.0003
904 EYE DISORDER 10 0.0003
905 JAUNDICE 8 0.0003
906 BONE MARROW FAILURE 6 0.0003
907 PRODUCT PRESCRIBING ERROR 7 0.0003
908 THERAPY CESSATION 15 0.0003
909 ILLNESS 30 0.0003
910 SYNCOPE 29 0.0003
911 PRESYNCOPE 7 0.0003
912 MYOCARDIAL INFARCTION 50 0.0003
913 RENAL IMPAIRMENT 24 0.0003
914 HYPERKALAEMIA 10 0.0003
915 DEPRESSED MOOD 15 0.0003
916 SKIN DISCOLOURATION 13 0.0003
917 PNEUMONIA ASPIRATION 7 0.0003
918 HIP FRACTURE 9 0.0003
919 PANCREATIC CARCINOMA 8 0.0003
920 HAEMATEMESIS 7 0.0003
921 COUGH 77 0.0003
922 RESTLESSNESS 10 0.0003
923 DYSURIA 10 0.0003
924 ANAPHYLACTIC SHOCK 7 0.0003
925 HAEMATOMA 7 0.0003
926 CORONARY ARTERY DISEASE 8 0.0003
927 PRODUCT AVAILABILITY ISSUE 6 0.0003
928 BLOOD PRESSURE INCREASED 40 0.0003
929 HYPOTENSION 52 0.0003
930 NERVOUS SYSTEM DISORDER 8 0.0003
931 FLATULENCE 14 0.0002
932 AGEUSIA 6 0.0002
933 EYE PRURITUS 8 0.0002
934 CARDIAC FAILURE CONGESTIVE 19 0.0002
935 PRODUCTIVE COUGH 11 0.0002
936 CHILLS 26 0.0002
937 DYSPHAGIA 21 0.0002
938 BALANCE DISORDER 19 0.0002
939 HEPATIC FUNCTION ABNORMAL 8 0.0002
940 HYPONATRAEMIA 12 0.0002
941 VISUAL ACUITY REDUCED 7 0.0002
942 CONSTIPATION 45 0.0002
943 OESOPHAGEAL CARCINOMA 6 0.0002
944 HEART RATE DECREASED 7 0.0002
945 PREMATURE BABY 6 0.0002
946 BRADYCARDIA 10 0.0002
947 RASH ERYTHEMATOUS 9 0.0002
948 EPISTAXIS 14 0.0002
949 DRUG DEPENDENCE 30 0.0002
950 SUICIDAL IDEATION 17 0.0002
951 DRUG EFFECT DECREASED 10 0.0002
952 MENTAL DISORDER 8 0.0002
953 FEBRILE NEUTROPENIA 12 0.0002
954 PULMONARY OEDEMA 8 0.0002
955 NERVOUSNESS 9 0.0002
956 DERMATITIS ATOPIC 9 0.0002
957 RHINORRHOEA 11 0.0002
958 ARRHYTHMIA 8 0.0002
959 HYPOGLYCAEMIA 8 0.0002
960 FEELING ABNORMAL 39 0.0002
961 DYSPNOEA EXERTIONAL 6 0.0002
962 RENAL FAILURE 21 0.0002
963 DYSKINESIA 6 0.0001
964 CHEST DISCOMFORT 14 0.0001
965 INFLUENZA LIKE ILLNESS 11 0.0001
966 VISION BLURRED 18 0.0001
967 RENAL CANCER 6 0.0001
968 SEIZURE 14 0.0001
969 HEART RATE INCREASED 12 0.0001
970 DYSPHONIA 7 0.0001
971 SURGERY 7 0.0001
972 CHRONIC KIDNEY DISEASE 9 0.0001
973 HYPERHIDROSIS 15 0.0001
974 DISTURBANCE IN ATTENTION 6 0.0001
975 INJECTION SITE PRURITUS 7 0.0001
976 LETHARGY 6 0.0001
977 PROSTATE CANCER 8 0.0001
978 EMOTIONAL DISTRESS 11 0.0001
979 DEHYDRATION 12 0.0001
980 CARDIAC DISORDER 7 0.0001
981 INJECTION SITE ERYTHEMA 9 0.0001
982 SKIN EXFOLIATION 6 0.0001
983 DRY SKIN 9 0.0001
984 PRODUCT DOSE OMISSION ISSUE 17 0.0001
985 TREMOR 9 0.0001
986 INCORRECT DOSE ADMINISTERED 7 0.0000
987 INJECTION SITE PAIN 7 0.0000